SY-005 （Recombinant Human Annexin A5）in Patients With Sepsis
Clinical trial NCT04898322 · UNKNOWN
Trial details
- NCT number
- NCT04898322
- Sponsor
- Suzhou Yabao Pharmaceutical R&D Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-02
- Primary completion
- 2023-07-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.